# JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)

> **NCT06287073** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 299 (actual)

## Conditions studied

- Kidney Disease, Chronic

## Interventions

- **DRUG:** JARDIANCE®

## Key facts

- **NCT ID:** NCT06287073
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-29
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06287073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06287073, "JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06287073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*